A1 Journal article – refereed
Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies)




List of Authors: Saarinen NM, Warri A, Makela SI, Eckerman C, Reunanen M, Ahotupa M, Salmi SM, Franke AA, Kangas L, Santti R
Publisher: LAWRENCE ERLBAUM ASSOC INC
Publication year: 2000
Journal: Nutrition and Cancer
Journal name in source: NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
Journal acronym: NUTR CANCER
Volume number: 36
ISSN: 0163-5581

Abstract
The potential for the extraction of the plant lignan hydroxymatairesinol (HMR) in large scale from Norway spruce (Picea abies) has given us the opportunity to study the metabolism and biological actions of HMR in animals. HMR, the most abundant single component of spruce lignans, was metabolized to enterolactone (ENL) as the major metabolite in rats after oral administration. The amounts of urinary ENL increased with the close of HMR (from 3 to 50 mg/kg), and only minor amounts of unmetabolized HMR isomers and other lignans were found in urine. HMR (15 mg/kg body wt po) given for 51 days decreased the number of growing tumors and increased the proportion of regressing and stabilized tumors in the rat dimethylbenz[a]anthracene-induced mammary tumor model. HMR (50 mg/kg body wt) did not exert estrogenic or antiestrogenic activity in the uterine growth test in immature rats. HMR also showed no antiandrogenic responses in the growth of accessory sex glands in adult male rats. Neither ENL nor enterodiol showed estrogenic or antiestrogenic activity via a classical alpha- or beta-type estrogen receptor-mediated pathway in vitro at <1.0 mu M. HMR was an effective antioxidant in vitro.

Last updated on 2019-20-07 at 09:22